Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. Methods In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. Results Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on negative placebo‐controlled data, we do not recommend paroxetine (level 2 negative).245”
In the citing paper
“Antimanic medications reduce depressive symptoms in only one-third of patients (2).”
From Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial (2018) · cites this paper as [2]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 4
- Murray CJ, 1994, Bull World Health Organ, 72, 495
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- 10.1037/0021-843X.108.4.579 · doi:10.1037/0021-843x.108.4.579 · Paper page
Cited by
Items 601–700 of 935
Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Aarre, T. F., & Dahl, A. A. (2008) · Current Psychiatry Reviews · doi:10.2174/157340008785829913 · Cited by 3
“But the only placebo-controlled trials undertaken [27, 36], point to the conclusion that paroxetine may be unhelpful for people with bipolar depression.”
BackgroundMethodInfluentialSubstance Abuse and Switch From Depression to Mania in Bipolar Disorder
Goldberg, J. F. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030367 · Cited by 3
Family-Focused Therapy Study Raises New Questions
Swartz, H. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020217 · Cited by 3
Bipolar Phenomenology: Have We Learned All We Can Learn?
Schneck, C. D. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10101482 · Cited by 4
Do effectiveness studies tell us the real truth?
Möller, H. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701534935 · Cited by 3
“For example, a study on the effectiveness of adjunctive antidepressant treatment in bipolar disorder (Sachs et al. 2007), the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), enrolled only 366 of the 4360 patients initially screened (only 2689 of the 4360 patients had at…”
BackgroundFeng, L., Wang, W., Yin, C., Li, J., Zhang, X., Chang, X., Feng, Z., Zandt, M. V., You, S. C., Seager, S. L., et al. (2025) · Health Data Science · doi:10.34133/hds.0209 · Cited by 2
“For example, many antidepressant trials exclude patients at higher risk for mania, such as those with a coexisting substance abuse or those who have been hospitalized for manic episodes, which restricts the generalizability of the results [ 27 , 28 ].”
Porceddu, G., Pessina, E., Cattaneo, C. I., Martiadis, V., Bianca, C., Maina, G., & Rosso, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1744056 · Cited by 2
Chang, Y. B., & Baleja, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114932 · Cited by 2
“Additionally, recent clinical trials have demonstrated limited efficacy of some antidepressants, including paroxetine [108] and bupropion [109], in bipolar disorder.”
Strakowski, S. M. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.008 · Cited by 2
Choi-Kain, L. W., Rodriguez-Villa, A. M., Ilagan, G. S., & Iliakis, E. A. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.010 · Cited by 3
Ratheesh, A., Speed, M. S., Salagre, E., Berk, M., Rohde, C., & Østergaard, S. D. (2024) · Bipolar Disorders · doi:10.1111/bdi.13432 · Cited by 3
“Given the large proportion of patients receiving antidepressants, despite limited evidence for effectiveness in treating or preventing depression, 28,44,45 there is a need for trials to include subgroups where these medications may be effective, 46,47 like those without substance use, ADHD, and…”
Aripiprazole in Schizotypal Personality: A Case Report
Kumar, A., Pinjarkar, R., Anand, N., Manjula, M., & Math, S. B. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612a · Cited by 2
Licht, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00010-5 · Cited by 2
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2
Beach, S. R., Huffman, J. C., Baek, J. H., Treadway, M. T., Nierenberg, A. A., & Alpert, J. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.004 · Cited by 2
Self-citationKorean Medication Algorithm for Bipolar Disorder 2014: Depressive Episode
Seo, J. S., Bahk, W. M., Lee, J. G., Woo, Y. S., Jeong, J. H., Wang, H. R., Kim, M.-D., Sohn, I., Shim, S. H., Min, K. J., et al. (2014) · 대한정신약물학회지 · Cited by 3
Neuroprotection in Bipolar Depression
Aiken, C. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_15 · Cited by 2
Nolen, W. A. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00054.x · Cited by 2
“Finally, in the STEP-BD study, sertraline or bupropion as add-on to ongoing treatment with (among other medications) lithium or valproate was not found more effective than the addition of placebo (5).”
MethodAcute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine
Bobo, W. V., EPSTEIN, R. A., & Shelton, R. C. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s1945 · Cited by 2
Pharmacotherapy of bipolar disorder: current status and emerging options
Sandlin, E. K., Gao, Y., & El‐Mallakh, R. S. (2013) · Clinical Practice · doi:10.2217/cpr.13.85 · Cited by 2
Psychopharmacology of Bipolar II Depression and Bipolar Depression with Mixed Features
Hsin, H., & Suppes, T. M. (2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.2.136 · Cited by 2
Kavanagh, D. J., Connor, J. P., & Young, R. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_32 · Cited by 2
Recent advances in the biological treatment of mood disorders
McDonald, G., & Hallahan, B. P. (2009) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700000331 · Cited by 2
Serotonergic dysfunction in bipolar disorder
Lan, M. J., & Mann, J. J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.005 · Cited by 2
Neurochemical and Metabolic Imaging in Bipolar Disorder
Kim, J. E., Lyoo, I. K., & Renshaw, P. F. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199797608.003.0039 · Cited by 2
Diagnosing and treating bipolar disorder in primary care
Koirala, P., & Anand, A. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85gr.18003 · Cited by 2
Medication Treatment of Bipolar Disorder in Developmentally Disabled Children and Adolescents
Gutkovich, Z. A., & Carlson, G. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-09530-1_9 · Cited by 2
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Which psychosocial interventions in bipolar depression ?
Scott, J. L., & Étain, B. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70056-2 · Cited by 2
Andrade, C. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13f08410 · Cited by 2
Treatment of refractory bipolar depression
Thase, M. E. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0067-x · Cited by 2
“[8].”
Self-citationWhat's Up with Bipolar Disorder?
Suppes, T. M. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc415 · Cited by 2
Pharmacologic Treatment of Bipolar Disorder
Baldassano, C. F. (2010) · CNS Spectrums · doi:10.1017/s1092852900027772 · Cited by 2
The role of antidepressants in managing Bipolar II disorder
Goldberg, J. F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.011 · Cited by 2
Acute management of bipolar disorders
Singh, A., & Berk, M. (2008) · Australian Prescriber · doi:10.18773/austprescr.2008.042 · Cited by 2
Combined Treatment With CBT and Psychopharmacology
Lee, J., Hearon, B. A., & Otto, M. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803457-6.00006-4 · Cited by 2
Self-citationPharmacological Treatment Strategies for Acute Bipolar Depression
Kim, S. J. (2018) · 신경정신의학 · doi:10.4306/jknpa.2018.57.4.287 · Cited by 2
Electrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2
Management of Bipolar II Disorder
Parker, G. B., & Ketter, T. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch26 · Cited by 2
Self-citationThe Role of Antidepressants in Bipolar Disorder
Yerevanian, B. I. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch15 · Cited by 2
Bringing a research base to psychiatry
Shuchman, M., Hébert, P. C., Kale, R., Sibbald, B., Flegel, K., & MacDonald, N. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080530 · Cited by 3
Brunoni, A. R. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000100022 · Cited by 2
Course and outcome of bipolar disorder — focusing on depressive aspects
Treuer, T., & Tohen, M. F. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_3 · Cited by 3
“A recent double-blind controlled trial showed that the use of adjunctive, standard antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy or with increased risk of treatment-emergent affective switch [ 39 ].”
BackgroundClassification and Epidemiology of Bipolar Disorder
Jauhar, S., & Cavanagh, J. (2013) · Wiley eBooks · doi:10.1002/9781118316153.ch11 · Cited by 2
Psychotropic Medication Use in Older People
Hopwood, M. (2007) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2007.tb00045.x · Cited by 2
Behavioural Activation Interventions for Depression and Well-being
Mazzucchelli, T. G. (2010) · eSpace (Curtin University) · Cited by 3
Goldberg, J. F. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20ed13649 · Cited by 2
Moshier, S. J., & Otto, M. W. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt50 · Cited by 2
Self-citationEfficacité des antipsychotiques et recommandations thérapeutiques
Franck, N., Fromager, F., & Thibaut, F. (2015) · Cited by 3
Takaesu, Y., Shiroma, A., & Nosaka, T. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70036 · Cited by 1
Zhao, W., Garza, J. C., Perlis, R. H., & Haggarty, S. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00014-4 · Cited by 1
Connery, H. S., Albanese, M. J., DeVido, J. J., Hill, K. P., McHugh, R. K., Sarvey, D. B., Suzuki, J., & Weiss, R. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.009 · Cited by 1
Fung, S. S.-P. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01054-z · Cited by 1
“The evidence for the efficacy of antidepressants in bipolar depression is mixed, with the largest randomized control trial (RCT) not finding any significant improvement of antidepressants over placebo when used as an adjunct to mood stabilisers in this indication [9].”
Omri, M., Ferhi, M., Rauschenbach, C., Ibrahim, A. A., Galvao, M. O., & Hamm, O. (2024) · Cureus · doi:10.7759/cureus.73980 · Cited by 2
Lumateperone-induced mania: A case series
Mudgal, V., Gaurav, P., Jain, P., & Chaturvedi, K. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_1261_25 · Cited by 1
Characteristics of Hispanic Women Screened for Postpartum Depression
Wisner, K. L., Lara-Cinisomo, S., Pinheiro, E. A., & Luther, J. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8045-7_1 · Cited by 1
Treatment of Pediatric Bipolar Disorder
Erdoğan, A., Kurban, S., & Yalçın, Ö. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20130707024051 · Cited by 1
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., Greil, W., & von Stralendorff, I. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50013-7 · Cited by 1
Actualización del tratamiento del trastorno bipolar
Goikolea, J. M. (2008) · Jano: Medicina y humanidades · Cited by 1
Treatment of the psychiatric patient
Chepenik, L. G., & Mallory, M. N. S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088077.026 · Cited by 2
Treatment ofpsychiatric illness in the emergency department
Nordstrom, K. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088077.032 · Cited by 1
The Nature and Treatment of Bipolar Disorder and the Bipolar Spectrum
Otto, M. W., & Applebaum, A. J. (2014) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199328710.013.035 · Cited by 1
Self-citationA commentary on "Sleep disturbance in bipolar disorder."
Thase, M. E. (2009) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2009.01165.x · Cited by 1
Self-citationThe role of antipsychotics and mood stabilizers in the treatment of bipolar disorder
Correll, C. U. (2011) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 2
Managing Late-Life Bipolar Disorder: An Update
Chen, P., Korobkova, I., Busby, K. K., & Sajatovic, M. (2011) · Aging Health · doi:10.2217/ahe.11.49 · Cited by 1
Long-term prospective mood self-rating and antidepressant treatment
Gadde, S., Brown, C., Shah, A., & El‐Mallakh, R. S. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011721 · Cited by 1
Perils of Pragmatic Psychiatry: How We Can Do Better
Koola, M. M., & Sebastian, J. (2016) · Psychiatry Depression & Anxiety · doi:10.24966/pda-0150/100002 · Cited by 1
Recognising Bipolar Disorders in Primary Care.
Dietch, D. (2015) · PubMed · Cited by 3
Shaywitz, J., & Marder, S. R. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199565498.003.0109 · Cited by 3
Bayesian prognostic model for genomic discovery in bipolar disorder
Bobba, S. S., Zollanvari, A., & Alterovitz, G. (2014) · IEEE Healthcare Innovation Conference (HIC) · doi:10.1109/hic.2014.7038921 · Cited by 1
Antidepressants triggering suicidal ideation: An area of concern
Malhotra, S., Rajgadhi, H., Gupta, S. D., Thakor, A. V., & Patel, P. (2016) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.194842 · Cited by 1
Novel Therapeutics in Bipolar Disorder
da Costa, S. C., Machado‐Vieira, R., & Soares, J. C. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0140-6 · Cited by 1
Bipolar I Mania and Atypical Depression
Mallmann, M. B., Lopes, F. L., & Veras, A. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-68309-8.00007-2 · Cited by 1
Recommandations thérapeutiques relatives aux troubles bipolaires
Hasler, G., Preisig, M., Müller, T., HolsboerTrachsler, E., Conus, P., Aubry, J., & Greil, W. (2011) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2011.07503 · Cited by 1
Lumateperone for major depressive episodes in bipolar I or bipolar II disorder
Meyer, J. M. (2021) · Current Psychiatry · doi:10.12788/0227 · Cited by 1
Medikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_54 · Cited by 4
The Relationship between Aromatherapy and Mental Wellbeing: A Narrative Review
AL-Mansour, B. (2022) · Unisia · doi:10.20885/unisia.vol40.iss2.art6 · Cited by 2
“Only approximately one-quarter of patients with bipolar disorders fully recover from an acute depressive episode (Sachs et al., 2007).”
BackgroundCetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Herbst, L., Marengo, E., Torrente, F. M., Maresca, T., Bustin, J., Morra, C. A., et al. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i161.488 · Cited by 2
Actualización en el uso y el manejo del litio en neuropsiquiatría
Corrales, A., Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Mato, A. M. L., Marengo, E., Abraham, E., Maresca, T., Bagnati, P. R. A. D. N., et al. (2024) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i162.504 · Cited by 2
Chapter 9. Augmentation Strategies for Treatment-Resistant Disorders
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551289.cd09 · Cited by 1
Park, J. H., Breitinger, S. A., Savitz, S. T., Gardea‐Resendez, M., Singh, B., Williams, M. D., & Frye, M. A. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.011 · Cited by 2
Pharmacological treatment of acute bipolar depression
Sachs, G. S., Sylvia, L. G., & Lund, H. G. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_9 · Cited by 1
“and an antidepressant (bupropion or paroxetine) [ 19 ].”
BackgroundSelf-citationPractical treatment guidelines for management of bipolar disorder
Yatham, L. N. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.005 · Cited by 1
Comorbidity of Social Anxiety Disorder and Attention Deficit Hyperactivity Disorder
Koyuncu, A., & Binbay, Z. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20130726020101 · Cited by 5
“Son dönemde yapılan bir çalışmada ise, bipolar depresyonda eşzamanlı duygudurum dengeleyicisi ile birlikte antidepresan kullanımı, antidepresan etkinliğin artması ya da kayma riskinin artışı ile ilişkili bulunmamıştır [92] Bu konuda tartışmalar olsa da, Akiskal ve Malya, antidepresana bağlı hipomaniyi soft bipolar spe…”
Suicide Attempt and Psychosis Revealed After an Apparent Traffic Accident: A Case Report
Ojha, R. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612g · Cited by 1
Sher, L. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000100024 · Cited by 1
Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes?
O’Malley, A. J., Zelevinsky, K., He, Y., & Busch, A. B. (2015) · Medical Care · doi:10.1097/mlr.0000000000000429 · Cited by 2
“Because RCT care is subjected to study protocols (eg, involving the evaluation and monitoring of patients), we secondly hypothesize that site high RCT enrollment propensity will have a larger effect on patient recovery in the STEP-BD OBS arm than its RCT.”
MethodResultInfluentialBehandlung bipolarer Störungen
Grunze, H., Grunze, A., & Born, C. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_3 · Cited by 1
Mc, M., Rovera, C., Ciappolino, V., Di Pace, C., Paletta, S., Reggiori, A., & Ac, A. (2016) · Dual Diagnosis Open Access · doi:10.21767/2472-5048.100021 · Cited by 1
“The common practice to use antidepressants often as monotherapy to treat BD I and particularly BD II depressed patients should be considered with great attention and caution by clinicians [46].”
BackgroundMcCutcheon, R. A., Kaar, S. J., & Howes, O. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.011 · Cited by 1
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Psychopharmacology and Neurotherapeutics
Seiner, S. J., Baldessarini, R. J., Camprodon, J. A., Dougherty, D. D., Givon, L., DeVido, J. J., & Alpert, J. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.015 · Cited by 1
Global Health and Mental Health Care Delivery in Low-Resource Settings
Raviola, G. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.020 · Cited by 1
Treating bipolar disorder with rapid cycles: About a case
Lucchelli, J. P., Kourakou, S., & Ciraselli, N. (2021) · L Encéphale · doi:10.1016/j.encep.2021.06.019 · Cited by 1
Bauer, M., Severus, E., & Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_68 · Cited by 1
Augmentation Strategies for Treatment-Resistant Disorders
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as09 · Cited by 1
Perlis, R. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50032-9 · Cited by 1
Psychopharmacological Recovery-Oriented Treatments in Bipolar Disorders
Cuomo, A., Spiti, A., Chioccioli, M., Koukouna, D., Goracci, A., Bolognesi, S., & Fagiolini, A. M. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_12 · Cited by 1
Metadata
- Authors
- Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Oklahoma (US)
- Stanford Medicine (US)
- University of Massachusetts Chan Medical School (US)
- University of Toledo (US)
- University of Colorado Boulder (US)
- Boston University (US)
- Purdue University West Lafayette (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-26
- Volume
- 356
- Issue
- 17
- Pages
- 1711-1722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166423384
- Semantic Scholar
- c224a40d0ffd6471e7b72b38060d169ba1cdec34
- Cited by
- 937
- References
- 27
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 68 · 2020: 33 · 2019: 29 · 2018: 36 · 2017: 28 · 2016: 53 · 2015: 47 · 2014: 51 · 2013: 52 · 2012: 61
- FWCI
- 56.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh80001-12-0-0)
- National Institute of Mental Health (N01-MH80001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar depression, adjunctive antidepressant therapy, mood stabilizers, euthymia, bipolar disorder, antidepressant safety
- MeSH terms
- Adult, Bipolar Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Bupropion, Treatment Outcome, Paroxetine, Antidepressive Agents, Second-Generation, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.